Recurrence of infusion-related reaction (IRRs) associated to avimantamab

被引：0

作者：

Becerra, M. V. Sanchez ^{[1
]}

Tagliamento, M. ^{[2
]}

Aldea, M. ^{[3
]}

Masip, J. Remon ^{[4
]}

Gazzah, A. ^{[5
]}

Vasseur, D. ^{[6
]}

Lavaud, P. ^{[3
]}

Frelaut, M. ^{[2
]}

Abdayem, P. ^{[7
]}

Meyer, M-L. ^{[8
]}

Ghigna, M. R. ^{[9
]}

Levy, A. ^{[10
]}

Botticella, A. ^{[10
]}

Aix, S. Ponce ^{[11
]}

Barlesi, F. ^{[2
]}

Planchard, D. ^{[3
]}

Besse, B. ^{[12
]}

机构：

[1] Gustave Roussy, Med Oncol, Alcorcon, Spain

[2] Gustave Roussy, Dept Med Oncol, Canc Campus, Villejuif, France

[3] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France

[4] Inst Gustave Roussy, Dept Oncol, Villejuif, France

[5] Inst Gustave Roussy, DITEP, Villejuif, France

[6] Gustave Roussy, Mol Biol, Canc Campus, Villejuif, France

[7] Gustave Roussy, Dept Canc Med, Canc Campus, Villejuif, France

[8] Gustave Roussy, Dept Med, Canc Campus, Villejuif, France

[9] Gustave Roussy, Anat Pathol, Canc Campus, Villejuif, France

[10] Gustave Roussy, Dept Radiat Oncol, Canc Campus, Villejuif, France

[11] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France

[12] Inst Gustave Roussy, Dept Canc Med, Villejuif, France

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.2447

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1416P

引用

页数：1

共 50 条

[1] Management of infusion-related reactions (IRRs) in patients receiving amivantamab
Park, K.
Sabari, J. K.
Haura, E. B.
Shu, C. A.
Spira, A.
Salgia, R.
Reckamp, K. L.
Sanborn, R. E.
Govindan, R.
Bauml, J. M.
Curtin, J. C.
Xie, J.
Roshak, A.
Lorenzini, P.
Millington, D.
Thayu, M.
Knoblauch, R. E.
Cho, B. C.
ANNALS OF ONCOLOGY, 2021, 32 : S981 - S982
[2] Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study
Park, Keunchil
Sabari, Joshua K.
Haura, Eric B.
Shu, Catherine A.
Spira, Alexander
Salgia, Ravi
Reckamp, Karen L.
Sanborn, Rachel E.
Govindan, Ramaswamy
Bauml, Joshua M.
Curtin, Joshua C.
Xie, John
Roshak, Amy
Lorenzini, Patricia
Millington, Dawn
Thayu, Meena
Knoblauch, Roland E.
Cho, Byoung Chul
LUNG CANCER, 2023, 178 : 166 - 171
[3] RituximabTachycardia as an infusion-related reaction: case report
Reactions Weekly, 2018, 1695 (1) : 325 - 325
[4] DaratumumabVarious infusion-related reaction: 7 case reports
Reactions Weekly, 2022, 1910 (1) : 170 - 170
[5] RituximabTingling throat as an infusion-related reaction: case report
Reactions Weekly, 2019, 1771 (1) : 270 - 270
[6] INFUSION-RELATED PHLEBITIS
COSENTINO, F
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (22): : 1454 - 1454
[7] CetuximabInterstitial pneumonia and infusion-related reaction: 2 case reports
Reactions Weekly, 2021, 1845 (1) : 127 - 127
[8] Agalsidase-αInfusion-related reaction in a child: case report
Reactions Weekly, 2011, 1352 (1) : 6 - 6
[9] Atezolizumab/BevacizumabGrade 4 infusion-related reaction: case report
Reactions Weekly, 2024, 2037 (1) : 67 - 67
[10] Anakinra/infliximabThrombocytopenia and infusion-related reaction: 2 case reports
Reactions Weekly, 2018, 1733 (1) : 45 - 45

← 1 2 3 4 5 →